Veterinary Medicines

BIOSUIS ParvoEry, Suspension for injection

Authorised
  • Porcine parvovirus, strain CAPM V198 S-27, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-64, Inactivated
Download as PDF

Product identification

Medicine name:
BIOSUIS ParvoEry, Suspension for injection
BIOSUIS ParvoEry, Injekční suspenze
Active substance:
  • Porcine parvovirus, strain CAPM V198 S-27, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-64, Inactivated
Target species:
  • Pig (sow)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Porcine parvovirus, strain CAPM V198 S-27, Inactivated
    4.00
    log2 haemagglutination inhibiting unit(s)
    /
    1.00
    Dose
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-64, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig (sow)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AL01
Legal status of supply:
  • Medicinal product subject to medical prescription
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Package description:
  • Glass Vial 1 x 10.0 millilitre(s)
  • Glass Vial 10 x 10.0 millilitre(s)
  • Glass Vial 1 x 50.0 millilitre(s)
  • Plastic Vial 1 x 50.0 millilitre(s)
  • Glass Vial 1 x 100.0 millilitre(s)
  • Plastic Vial 1 x 100.0 millilitre(s)
  • Plastic Vial 1 x 250.0 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/007/19-C
Date of authorisation status change:
Reference member state:
  • Czechia
Procedure number:
  • CZ/V/0148/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Croatia
  • Denmark
  • Estonia
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 12/09/2023
Download
Czech (PDF)
Published on: 12/09/2023
Download

Package Leaflet

English (PDF)
Published on: 12/09/2023
Download
Czech (PDF)
Published on: 12/09/2023
Download

Labelling

English (PDF)
Published on: 12/09/2023
Download
Czech (PDF)
Published on: 12/09/2023
Download

eu-puar-czv0148001-mr-biosuis_parvoery-en.pdf

English (PDF)
Published on: 16/11/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."